GlassScriptPhysician profile
Luis Herrera-Acevedo
NPI 1437140761
$1,250.25
in general payments reported to CMS, 2019-2025
9 companies · $56.84 in 2025
The $56.84 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $95.19 · 2021: $504 · 2022: $84.37 · 2023: $123 · 2024: $135 · 2025: $56.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $353.03 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $227.48 | 2019-2024 | Kristalose |
| Glaxosmithkline, LLC. | $203.05 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $154.93 | 2019-2023 | |
| Sanofi Pasteur INC. | $121.16 | 2019-2025 | |
| Pfizer INC. | $110.84 | 2019-2024 | |
| Biomarin Pharmaceutical INC. | $41.90 | 2024 | Voxzogo 1.2mg |
| Ultragenyx Pharmaceutical INC. | $19.56 | 2022 | |
| Cranial Technologies, INC | $18.30 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Herrera-Acevedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.